rs2305480 — GSDMB GSDMB Pro311Ser protective haplotype
Missense variant in gasdermin B that increases GSDMB expression and pyroptotic activity in airway epithelial cells, with the G (reference) allele conferring elevated childhood asthma risk through enhanced epithelial cell inflammatory death
Details
- Gene
- GSDMB
- Chromosome
- 17
- Risk allele
- G
- Clinical
- Risk Factor
- Evidence
- Strong
Population Frequency
Category
Allergy & Atopic DiseaseSee your personal result for GSDMB
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
Gasdermin B — The Airway Cell Pyroptosis Switch at the Heart of the 17q21 Asthma Locus
The 17q21 chromosomal region is the most replicated genetic risk locus for childhood asthma in the genome,
with associations reported across dozens of studies in European, African, East Asian, and South Asian
populations. For years, the gene driving this signal was assumed to be ORMDL311 ORMDL3
ORM1-like protein 3,
a transmembrane ER protein that regulates ceramide synthesis and the unfolded protein response,
whose expression is tightly regulated by 17q21 variants. But more recent functional work points to
its neighbor, GSDMB (gasdermin B), as the causal effector — specifically, GSDMB's ability to
trigger pyroptosis22 pyroptosis
A form of inflammatory programmed cell death in which cells release their contents
into the surrounding tissue, driving local inflammation — distinct from apoptosis, which is non-inflammatory
in airway epithelial cells.
rs2305480 sits within the GSDMB coding sequence on chromosome 17q21. On the plus (genomic) strand, the G allele is the reference, but it is also the risk allele: it encodes a proline at position 311 of the dominant GSDMB isoform, producing a protein with full pyroptotic capacity. The A allele, encoding serine at the same position (p.Pro311Ser), tags a haplotype carrying a protective splice variant (rs11078928) that removes exon 6 and abolishes GSDMB's ability to trigger inflammatory cell death. Most people carry at least one copy of the risk G allele — it is the population-major allele globally — making GG the most common genotype worldwide.
The Mechanism
GSDMB protein belongs to the gasdermin family, which evolved to perforate cell membranes under
specific inflammatory conditions. When airway epithelial cells are exposed to viral or bacterial
triggers, caspase-133 caspase-1
An inflammatory cysteine protease activated by the NLRP3 inflammasome in
response to microbial danger signals cleaves GSDMB,
releasing its N-terminal domain. This N-terminal fragment inserts into the cell membrane, forming
pores that trigger pyroptotic cell death and release pro-inflammatory signals — interleukin-1β
(IL-1β), IL-18, and HMGB1 — into the airway.
The splice variant tagged by the protective A allele at rs2305480 removes exon 6, which encodes
13 amino acids within the region essential for GSDMB's pore-forming activity. Without these
residues, the protein loses pyroptotic capacity even when caspase-1 cleaves it. Panganiban
et al.44 Panganiban
et al.
J Allergy Clin Immunol, 2018; multi-cohort study combining the GERA cohort and the
EVE Consortium (diverse ancestry) showed that the
G-allele haplotype (full pyroptotic GSDMB) confers risk while the A-allele haplotype (truncated,
non-pyroptotic GSDMB) is protective: combined OR 0.85 (P=1.31×10⁻¹³) in the EVE Consortium.
Beyond pyroptosis, the Das et al. review55 Das et al. review
Advances in Immunology, 2017; comprehensive review of
17q21 genes in asthma and immune diseases identified that
GSDMB also modulates 5-lipoxygenase (5-LO) expression and TGF-β1 signaling — two further pathways
that sustain airway inflammation and promote bronchial remodeling in asthma.
The Evidence
The GABRIEL Consortium GWAS66 GABRIEL Consortium GWAS
Moffatt et al., NEJM 2010; 10,365 asthma cases and 16,110
controls from 23 European studies established rs2305480-G
as a genome-wide significant risk allele for childhood-onset asthma (OR 1.18, 95% CI 1.11–1.23,
P=6×10⁻²³), with an effect specific to childhood-onset disease — no comparable association appeared
with adult-onset asthma. This age-specificity is consistent with GSDMB's role in shaping airway
epithelial responses during the critical window of early respiratory development.
A Danish GWAS of severe asthma exacerbations77 GWAS of severe asthma exacerbations
Bønnelykke et al., Nature Genetics 2014; 1,173
cases aged 2–6 years and 2,522 controls from national health registries
identified the GSDMB locus among the strongest hits, with OR 1.32 (95% CI 1.23–1.39), consistent
with a larger effect in younger children with more severe disease.
Critically, the signal extends across ancestries. Ober et al.88 Ober et al.
Lancet Respiratory Medicine,
2020; expression QTL fine-mapping in African American children
found that rs2305480 was the single most robust signal from the 17q21 locus in African Americans
(OR 1.36, 95% CI 1.12–1.65, P=0.0014) — and was the most significant eQTL for GSDMB expression
in upper airway epithelial cells in this population. This functional eQTL evidence directly
links the genetic signal to altered gene expression in the relevant tissue.
A 2025 large-scale study across 13,000+ preschool children99 13,000+ preschool children
Fischer-Rasmussen et al., J Allergy
Clin Immunol 2025; discovery in 15 cohorts, replication in 7 additional cohorts up to 5,000
children confirmed rs2305480 as a genome-wide significant
determinant of early-onset wheeze (OR 1.26, 95% CI 1.17–1.33, P=2.30×10⁻¹⁶).
In UK asthmatic children, Tulah et al.1010 Tulah et al.
BMC Medical Genetics, 2013; 370 UK families with
≥2 asthmatic children showed that the Ser311Pro
variant (rs2305480) associated not only with asthma diagnosis but with bronchial hyperresponsiveness
and disease severity — indicating it modulates how reactive the airways are to triggers, not merely
whether asthma is present.
Practical Actions
The practical implications of rs2305480 center on the early-childhood window when airway inflammatory programming occurs. For GG homozygotes, the key insight is that their airway epithelial cells produce full-activity GSDMB that releases inflammatory signals after respiratory infections — a process that is substantially amplified by environmental tobacco smoke exposure and respiratory viral infections in the first years of life. Actions focus on minimizing inflammatory triggers, optimizing lung function, and ensuring respiratory infections in childhood are treated promptly to limit airway inflammation.
For adults with GG genotype who already have asthma, the GSDMB mechanism suggests that biological triggers of NLRP3 inflammasome activation (respiratory infections, mold exposure, cockroach allergen) may be especially potent triggers compared to the population average.
Interactions
rs2305480 sits within the broader 17q21 asthma susceptibility block, which contains multiple variants in high linkage disequilibrium. The most important functional partners are:
rs11078928 — A splice-region variant that, when in combination with rs2305480-A on the same haplotype, directly removes exon 6 from GSDMB mRNA, eliminating pyroptotic activity. The combined A/A haplotype at these two positions produces the most protective profile.
rs8076131 — An ORMDL3 regulatory variant at the same locus that controls ER stress responses in airway epithelial cells independently of GSDMB. ORMDL3 and GSDMB effects may compound in the same airway cell population.
Gene-environment interaction: 17q21 risk genotype carriers show substantially higher associations between early-life respiratory infections and asthma onset compared to non-carriers, with ORs of 3.42–6.36 versus 1.84–2.44 in those without risk genotypes. Environmental tobacco smoke exposure in early life amplifies this interaction further.
Genotype Interpretations
What each possible genotype means for this variant:
Protective genotype — lowest GSDMB pyroptotic activity and reduced childhood asthma risk
You carry two copies of the A allele at rs2305480, the protective minority genotype at this locus. The A allele tags a haplotype carrying a splice variant (rs11078928) that removes exon 6 from GSDMB mRNA, producing a truncated protein that cannot trigger pyroptotic cell death in airway epithelial cells. Large multi-ancestry GWAS data (EVE Consortium, OR 0.85, P=1.31×10⁻¹³) confirm this genotype is associated with substantially reduced childhood asthma risk compared to GG homozygotes. About 19% of people globally carry this genotype; it is more common in European populations (~22%) and rarer in African populations (~2%).
One copy of the risk G allele — intermediate GSDMB pyroptotic activity and modestly elevated asthma susceptibility
You carry one G and one A allele at rs2305480. One of your GSDMB alleles produces full-activity protein capable of triggering pyroptosis in airway epithelial cells; the other allele (on the A-allele haplotype) produces a truncated, non-pyroptotic isoform. Your overall airway epithelial inflammatory response to respiratory infections sits between AA and GG homozygotes. The GWAS-estimated risk increase per G allele is approximately OR 1.18–1.32 for childhood-onset asthma, placing heterozygotes at modest intermediate risk. This is the most common genotype, carried by approximately 49% of people globally.
Two copies of the risk G allele — full GSDMB pyroptotic activity and highest childhood asthma susceptibility at this locus
The GG genotype at rs2305480 means both chromosomes carry the full-length GSDMB isoform without the exon 6 deletion that protects A-allele carriers. This protein, when cleaved by caspase-1 during innate immune activation, inserts its N-terminal domain into the airway epithelial cell membrane and triggers inflammatory cell death. The released signals (IL-1β, IL-18, HMGB1) amplify local airway inflammation and recruit additional immune cells, promoting the sustained airway inflammation that underlies asthma.
The 17q21 signal is specifically tied to childhood-onset asthma — the GABRIEL Consortium GWAS (10,365 cases across 23 European studies) found the association essentially confined to disease presenting before age 16, with P=6×10⁻²³ for childhood onset. This specificity reflects the developmental window during which GSDMB-mediated inflammatory responses to early-life viral and bacterial infections shape airway architecture. Adults with GG who do not have asthma are unlikely to develop new-onset disease due to this locus alone, but existing asthma patients with GG may have more reactive airways in the context of respiratory infections.
Gene-environment interactions documented at the broader 17q21 locus show that early-life environmental tobacco smoke exposure multiplies the locus's effect: children with 17q21 risk genotypes who are exposed to ETS show ORs of 3–7 for infection-triggered asthma, compared to 1.7–2.4 in unexposed risk-genotype carriers. This makes smoke-free early environments a genotype-specific high-priority action.